ReviewDrug design, development and therapy2013

Review of daclizumab and its therapeutic potential in the treatment of relapsing-remitting multiple sclerosis.

Jennifer Reardon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.